Table.

First choice of treatment of consultant urologists for clinical vignettes. Values are numbers (percentages) of consultants

Case No	Presenting characteristics*	No of consultants responding	Radical prostatectomy	Radical radiotherapy	Brachytherapy	Hormone (medical)	Hormone (surgical)	Surveillance only	Surveillance and hormone
1	Age 55, incidental, prostate specific antigen 7 ng/ml, transrectal ultrasound and magnetic resonance imaging results suggest localised tumour, Gleason score 3	211	136 (64)	49 (23)	1 (0.5)	3 (1)	0	16 (8)	6 (3)
2	Age 62, bladder outlet obstruction, prostate specific antigen 15 ng/ml, Gleason score 5 from chippings	202	80 (40)	82 (41)	0	7 (3)	3 (1)	10 (5)	20 (10)
3	Age 69, incidental, prostate specific antigen 16 ng/ml, transrectal ultrasound and magnetic resonance imaging results suggest localised tumour, Gleason score 3	206	50 (24)	85 (41)	2 (1)	13 (6)	0	27 (13)	29 (14)
4	Age 75, incidental, prostate specific antigen 20 ng/ml, transrectal ultrasound and magnetic resonance imaging results suggest localised tumour, Gleason score 3	218	0	51 (23)	0	22 (10)	1 (0.5)	52 (24)	92 (42)
5	Age 58, poorly differentiated localised tumour, prostate specific antigen 17 ng/ml, Gleason score 8	202	67 (33)	102 (50)	2 (1)	23 (11)	1 (0.5)	1 (0.5)	6 (3)

^*Normal values of prostate specific antigen are around 4 ng/ml. In Gleason grading system sections of tumour are graded from 1 (least aggressive) to 5 (most aggressive). The two highest grades from each tumour are added to give a score ranging from 2-10. Scores of 7 and above indicate worse prognosis than lower scores.